161 related articles for article (PubMed ID: 20538608)
1. Solution structure of the squash aspartic acid proteinase inhibitor (SQAPI) and mutational analysis of pepsin inhibition.
Headey SJ; MacAskill UK; Wright MA; Claridge JK; Edwards PJB; Farley PC; Christeller JT; Laing WA; Pascal SM
J Biol Chem; 2010 Aug; 285(35):27019-27025. PubMed ID: 20538608
[TBL] [Abstract][Full Text] [Related]
2. The squash aspartic proteinase inhibitor SQAPI is widely present in the cucurbitales, comprises a small multigene family, and is a member of the phytocystatin family.
Christeller JT; Farley PC; Marshall RK; Anandan A; Wright MM; Newcomb RD; Laing WA
J Mol Evol; 2006 Dec; 63(6):747-57. PubMed ID: 17103059
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the interaction between the aspartic peptidase inhibitor SQAPI and aspartic peptidases using surface plasmon resonance.
Farley PC; Christeller JT; Sullivan ME; Sullivan PA; Laing WA
J Mol Recognit; 2002; 15(3):135-44. PubMed ID: 12203839
[TBL] [Abstract][Full Text] [Related]
4. Purification, characterization and cloning of an aspartic proteinase inhibitor from squash phloem exudate.
Christeller JT; Farley PC; Ramsay RJ; Sullivan PA; Laing WA
Eur J Biochem; 1998 May; 254(1):160-7. PubMed ID: 9652409
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3.
Ng KK; Petersen JF; Cherney MM; Garen C; Zalatoris JJ; Rao-Naik C; Dunn BM; Martzen MR; Peanasky RJ; James MN
Nat Struct Biol; 2000 Aug; 7(8):653-7. PubMed ID: 10932249
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
Tate S; Ushioda T; Utsunomiya-Tate N; Shibuya K; Ohyama Y; Nakano Y; Kaji H; Inagaki F; Samejima T; Kainosho M
Biochemistry; 1995 Nov; 34(45):14637-48. PubMed ID: 7578072
[TBL] [Abstract][Full Text] [Related]
7. Wild-type and met-65-->Leu variants of human cystatin A are functionally and structurally identical.
Craven CJ; Baxter NJ; Murray EH; Hill NJ; Martin JR; Ylinenjärvi K; Björk I; Waltho JP; Murray IA
Biochemistry; 2000 Dec; 39(51):15783-90. PubMed ID: 11123903
[TBL] [Abstract][Full Text] [Related]
8. X-ray crystallography and NMR studies of domain-swapped canecystatin-1.
Valadares NF; de Oliveira-Silva R; Cavini IA; Marques Ide A; Pereira HD; Soares-Costa A; Henrique-Silva F; Kalbitzer HR; Munte CE; Garratt RC
FEBS J; 2013 Feb; 280(4):1028-38. PubMed ID: 23241243
[TBL] [Abstract][Full Text] [Related]
9. Involvement of a residue at position 75 in the catalytic mechanism of a fungal aspartic proteinase, Rhizomucor pusillus pepsin. Replacement of tyrosine 75 on the flap by asparagine enhances catalytic efficiency.
Park YN; Aikawa J; Nishiyama M; Horinouchi S; Beppu T
Protein Eng; 1996 Oct; 9(10):869-75. PubMed ID: 8931126
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional solution structure of oryzacystatin-I, a cysteine proteinase inhibitor of the rice, Oryza sativa L. japonica.
Nagata K; Kudo N; Abe K; Arai S; Tanokura M
Biochemistry; 2000 Dec; 39(48):14753-60. PubMed ID: 11101290
[TBL] [Abstract][Full Text] [Related]
11. Plant protein proteinase inhibitors: structure and mechanism of inhibition.
Bateman KS; James MN
Curr Protein Pept Sci; 2011 Aug; 12(5):340-7. PubMed ID: 21418022
[TBL] [Abstract][Full Text] [Related]
12. X-ray analyses of aspartic proteinases. V. Structure and refinement at 2.0 A resolution of the aspartic proteinase from Mucor pusillus.
Newman M; Watson F; Roychowdhury P; Jones H; Badasso M; Cleasby A; Wood SP; Tickle IJ; Blundell TL
J Mol Biol; 1993 Mar; 230(1):260-83. PubMed ID: 8450540
[TBL] [Abstract][Full Text] [Related]
13. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.
Premzl A; Puizdar V; Zavasnik-Bergant V; Kopitar-Jerala N; Lah TT; Katunuma N; Sloane BF; Turk V; Kos J
Biol Chem; 2001 May; 382(5):853-7. PubMed ID: 11517941
[TBL] [Abstract][Full Text] [Related]
14. Shewasin A, an active pepsin homolog from the bacterium Shewanella amazonensis.
Simões I; Faro R; Bur D; Kay J; Faro C
FEBS J; 2011 Sep; 278(17):3177-86. PubMed ID: 21749650
[TBL] [Abstract][Full Text] [Related]
15. Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN.
Hiltke TR; Lee TC; Bobek LA
J Dent Res; 1999 Aug; 78(8):1401-9. PubMed ID: 10439027
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis of the 85-kilodalton crystalline cysteine proteinase inhibitor from potato releases functional cystatin domains.
Walsh TA; Strickland JA
Plant Physiol; 1993 Dec; 103(4):1227-34. PubMed ID: 8290629
[TBL] [Abstract][Full Text] [Related]
17. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
Pol E; Björk I
Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of a sweet protein: NMR study of MNEI, a single chain monellin.
Spadaccini R; Crescenzi O; Tancredi T; De Casamassimi N; Saviano G; Scognamiglio R; Di Donato A; Temussi PA
J Mol Biol; 2001 Jan; 305(3):505-14. PubMed ID: 11152608
[TBL] [Abstract][Full Text] [Related]
19. X-ray analyses of aspartic proteinases. II. Three-dimensional structure of the hexagonal crystal form of porcine pepsin at 2.3 A resolution.
Cooper JB; Khan G; Taylor G; Tickle IJ; Blundell TL
J Mol Biol; 1990 Jul; 214(1):199-222. PubMed ID: 2115088
[TBL] [Abstract][Full Text] [Related]
20. Engineering of porcine pepsin. Alteration of S1 substrate specificity of pepsin to those of fungal aspartic proteinases by site-directed mutagenesis.
Shintani T; Nomura K; Ichishima E
J Biol Chem; 1997 Jul; 272(30):18855-61. PubMed ID: 9228062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
